Antimicrobial Resistance Diagnostics Market, By Product Type (Reagents & Consumables and Instruments), By Pathogen Type, By Technology, By End Use, By Country, and By Region Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
|
Report ID
AV4155
|
Published Date
July 2025
|
Pages
288
|
Industry
Healthcare
|
|
|
Base Year
2025
|
Historical Data
2019-2024
|
Delivery Timeline
24 Hour
|
REPORT HIGHLIGHT
Antimicrobial Resistance Diagnostics Market size was valued at US$ 4,610.22 Million in 2024, expanding at a CAGR of 6.90% from 2025 to 2032.
The Antimicrobial Resistance (AMR) Diagnostics Market is a global industry dedicated to the development, production, and commercialization of diagnostic tools and technologies designed to detect antimicrobial-resistant pathogens. These diagnostics play a critical role in identifying resistance patterns in bacteria, viruses, fungi, and parasites, enabling healthcare professionals to prescribe effective treatments and minimize the misuse of antimicrobials. The market encompasses a range of technologies, including molecular diagnostics, immunoassays, microbiological methods, and rapid point-of-care tests, which are used across clinical, hospital, and research settings. With the growing threat of antimicrobial resistance worldwide, there is a rising demand for timely and accurate diagnostic solutions. This trend is fueling innovation and attracting significant investment in the AMR diagnostics sector.
Antimicrobial Resistance Diagnostics Market- Market Dynamics
Rising Adoption of Rapid and Point-of-Care Diagnostic Technologies for Timely Treatment Decisions
Rapid and point-of-care (POC) diagnostic technologies are playing an increasingly vital role in the fight against antimicrobial resistance (AMR). These tools allow healthcare professionals to quickly detect resistant infections and provide targeted treatments, reducing reliance on broad-spectrum antibiotics. Unlike traditional laboratory tests that can take several days, rapid and POC diagnostics deliver results within minutes or hours, enabling faster clinical decisions and minimizing inappropriate antibiotic use. According to a 2023 report by the World Health Organization (WHO), the use of rapid diagnostics can reduce unnecessary antibiotic prescriptions by 30–40%, significantly decreasing the risk of resistance development. Timely and accurate detection also improves patient outcomes by enabling prompt, appropriate treatment, shortening hospital stays, and helping prevent the spread of resistant pathogens within healthcare settings.
The growing availability of portable POC devices is especially beneficial in remote and resource-limited areas, where access to advanced laboratory infrastructure is limited. These devices ensure broader global access to essential diagnostic tools, strengthening efforts to control AMR worldwide. In March 2025, Abbott Laboratories introduced a new rapid molecular diagnostic test capable of detecting multiple antimicrobial-resistant pathogens in under an hour. This innovation supports better infection control in hospitals by enabling quick identification and isolation of resistant cases, thereby enhancing patient care and antibiotic stewardship.
Antimicrobial Resistance Diagnostics Market- Segmentation Analysis:
The global antimicrobial resistance diagnostics market is segmented on the basis of product type, pathogen type, technology, end use and region.
The antimicrobial resistance (AMR) diagnostics market is segmented by product type into two primary categories: reagents & consumables, and instruments. Among these, the reagents & consumables segment dominates the market. This is largely due to their indispensable role in diagnostic testing—while instruments are often a one-time investment, reagents and consumables are required for every individual test, leading to continuous and recurring demand. Healthcare facilities and laboratories consistently replenish their stocks to maintain seamless diagnostic operations. These products are compatible with a wide range of diagnostic platforms, including molecular diagnostics, immunoassays, and culture-based techniques, further enhancing their utility across diverse clinical settings. The development of new diagnostic technologies often brings about the need for novel reagents tailored to specific pathogens or resistance markers, which further expands the market. According to the World Health Organization (WHO), global consumption of antibiotics rose by 65% between 2000 and 2015, driving the need for accurate diagnostics—and subsequently, for reagents and consumables—to manage rising resistance effectively.
In terms of end-users, the market is segmented into hospitals, diagnostic laboratories, pharmaceutical & biotechnology companies, research institutes, and others. Hospitals hold the largest share in this segment, primarily because they serve as the first point of contact for patients and are central to the diagnosis and treatment of infections. The high incidence of hospital-acquired infections (HAIs) and the critical necessity of combating antimicrobial resistance make hospitals key buyers of advanced diagnostic tools. These institutions typically have the infrastructure, trained personnel, and financial resources necessary to deploy sophisticated AMR diagnostic systems. Additionally, hospitals are integral to infection control and antibiotic stewardship programs, which are crucial for monitoring and mitigating resistance trends. As reported by the U.S. Centers for Disease Control and Prevention (CDC), about 1 in 31 hospital patients has at least one healthcare-associated infection on any given day, highlighting the urgent need for effective diagnostic solutions within hospital settings.
Antimicrobial Resistance Diagnostics Market- Geographical Insights
In 2024, North America dominated the global antimicrobial resistance (AMR) diagnostics market, holding a market share of 45.71%.
North America continues to be the largest and most established market for antimicrobial resistance (AMR) diagnostics, driven by its advanced healthcare infrastructure, significant investment in research and development, and high overall healthcare spending. The region benefits from the strong presence of leading diagnostic companies and the widespread implementation of comprehensive antimicrobial stewardship programs.
Government-supported initiatives, such as the U.S. National Action Plan for Combating Antibiotic-Resistant Bacteria, have further accelerated the adoption of advanced diagnostic technologies. Hospitals and clinical laboratories across North America place a strong emphasis on the early and accurate detection of resistant pathogens to enhance patient outcomes and reduce the incidence of healthcare-associated infections. Moreover, the region’s well-developed reimbursement systems and favorable regulatory environment encourage continued innovation and investment in the development and commercialization of next-generation AMR diagnostic tools, reinforcing North America\'s leadership in the global market.
Asia-Pacific is projected to record the highest compound annual growth rate (CAGR) in the antimicrobial resistance (AMR) diagnostics market during the 2024 forecast period.
The Asia-Pacific region is emerging as the fastest-growing market for antimicrobial resistance (AMR) diagnostics, driven by a combination of key factors such as a rapidly expanding population, increasing urbanization, and a growing incidence of infectious diseases caused by resistant pathogens. Countries including China, India, Japan, and South Korea are making significant strides in strengthening their healthcare infrastructure, with a heightened focus on infectious disease management and expanding diagnostic capabilities.
Governments across the region are actively launching awareness campaigns and implementing regulatory measures to monitor and control AMR, thereby driving demand for rapid, affordable, and efficient diagnostic solutions. Additionally, the rise of a growing middle-class population and improved access to healthcare services have expanded the patient base seeking timely diagnosis and targeted treatment. The increasing prevalence of multidrug-resistant infections, coupled with rising healthcare investments and strategic collaborations between domestic and international diagnostic companies, positions Asia-Pacific as a high-potential market with strong growth prospects in the coming years.
Antimicrobial Resistance Diagnostics Market- Competitive Landscape:
The antimicrobial resistance (AMR) diagnostics market is highly competitive, featuring numerous global and regional players focused on innovation, strategic partnerships, and new product launches to strengthen their market positions. Leading companies invest significantly in research and development to deliver rapid, accurate, and cost-effective diagnostic solutions that meet the growing demand for timely detection of resistant pathogens.
Key market players include Roche Diagnostics, Abbott Laboratories, bioMérieux, Danaher Corporation (Cepheid), QIAGEN, and Thermo Fisher Scientific. These companies leverage their broad product portfolios and extensive distribution networks to maintain a competitive advantage. Additionally, they collaborate with healthcare institutions and government bodies to expand their market reach and support AMR surveillance programs. The market is characterized by continuous technological advancements, such as the development of multiplex molecular assays and point-of-care testing platforms, which enable faster and more precise results. Mergers and acquisitions are also common strategies used to enhance capabilities and enter new markets. This competitive environment fosters ongoing innovation, improving diagnostic accuracy and patient outcomes in the global fight against antimicrobial resistance.
Recent Developments:
- March 2025: bioMérieux received FDA 510(k) clearance for its VITEKCOMPACTPRO, a next-generation system that combines microorganism identification with antibiotic susceptibility testing. This launch enhances clinical laboratories\' ability to rapidly detect resistant pathogens, supporting targeted treatments and better patient management in combating AMR.
- July 2024: QIAGEN announced a collaboration with a global healthcare provider to deploy its QIAstat-Dx Analyzer in regional clinics for rapid AMR diagnostics. This partnership aims to improve access to fast and accurate resistance testing beyond traditional hospital settings, facilitating early intervention.
- September 2024: Thermo Fisher Scientific launched a new PCR-based diagnostic kit designed for rapid detection of antimicrobial-resistant pathogens in hospital environments. This innovation strengthens Thermo Fisher\'s position in the AMR diagnostics market by providing fast, reliable testing essential for effective antibiotic stewardship.
- July 2022: Boehringer Ingelheim, together with life sciences company Evotec SE and bioMérieux, announced a joint venture to develop next-generation antimicrobials and actionable diagnostics to combat AMR. This collaboration has expanded the companies’ product offerings for AMR diagnosis and treatment.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTICS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- Abbott Laboratories
- Accelerated Diagnostics, USA
- Alifax
- BD
- Beckman Coulter
- Becton, Dickinson and Company
- BioMerieux
- Bio-Rad Laboratories
- Danaher
- F. Hoffmann-La Roche
- GeneFluidics
- Hologic, Inc.
- Molsid
- OpGen
- Roche Diagnostics
- Thermo Fisher Scientific
- Vela Diagnostics
- Visby Medical, Inc.
- Others
GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTICS MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032
- Reagents & Consumables
- Instruments
GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTICS MARKET, BY PATHOGEN TYPE- MARKET ANALYSIS, 2019 - 2032
- Clostridium difficile (CD)
- Drug-resistant campylobacter (DRC)
- Drug-resistant Neisseria gonorrhoeae (DRNG)
- Drug-resistant streptococcus pneumoniae (DRSP)
- Methicillin-resistant Staphylococcus aureus (MRSA)
- Other pathogen types
GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTICS MARKET, BY TECHNOLOGY - MARKET ANALYSIS, 2019 - 2032
- Immunoassay
- Mass spectrometry
- Microbiology culture
- Next generation sequencing (NGS)
- Polymerase chain reaction (PCR)
- Rapid & point of care
- Other technologies
GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTICS MARKET, BY END USE - MARKET ANALYSIS, 2019 - 2032
- Diagnostic Laboratories
- Hospitals
- Pharmaceutical & Biotechnology Companies
- Research Institutes
- Others
GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTICS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
TABLE OF CONTENT
1. Antimicrobial Resistance Diagnostics Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Antimicrobial Resistance Diagnostics Market Snippet by Product Type
2.1.2. Antimicrobial Resistance Diagnostics Market Snippet by Pathogen Type
2.1.3. Antimicrobial Resistance Diagnostics Market Snippet by Technology
2.1.4. Antimicrobial Resistance Diagnostics Market Snippet by End Use
2.1.5. Antimicrobial Resistance Diagnostics Market Snippet by Country
2.1.6. Antimicrobial Resistance Diagnostics Market Snippet by Region
2.2. Competitive Insights
3. Antimicrobial Resistance Diagnostics Key Market Trends
3.1. Antimicrobial Resistance Diagnostics Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Antimicrobial Resistance Diagnostics Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Antimicrobial Resistance Diagnostics Market Opportunities
3.4. Antimicrobial Resistance Diagnostics Market Future Trends
4. Antimicrobial Resistance Diagnostics Industry Study
4.1. PESTEL Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Antimicrobial Resistance Diagnostics Market: Impact of Escalating Geopolitical Tensions
5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts
6. Antimicrobial Resistance Diagnostics Market Landscape
6.1. Antimicrobial Resistance Diagnostics Market Share Analysis, 2024
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Antimicrobial Resistance Diagnostics Market – By Product Type
7.1. Overview
7.1.1. Segment Share Analysis, By Product Type, 2024 & 2032 (%)
7.1.2. Reagents & Consumables
7.1.3. Instruments
8. Antimicrobial Resistance Diagnostics Market – By Pathogen Type
8.1. Overview
8.1.1. Segment Share Analysis, By Pathogen Type, 2024 & 2032 (%)
8.1.2. Clostridium difficile (CD)
8.1.3. Drug-resistant campylobacter (DRC)
8.1.4. Drug-resistant Neisseria gonorrhoeae (DRNG)
8.1.5. Drug-resistant streptococcus pneumoniae (DRSP)
8.1.6. Methicillin-resistant Staphylococcus aureus (MRSA)
8.1.7. Other pathogen types
9. Antimicrobial Resistance Diagnostics Market – By Technology
9.1. Overview
9.1.1. Segment Share Analysis, By Technology, 2024 & 2032 (%)
9.1.2. Immunoassay
9.1.3. Mass spectrometry
9.1.4. Microbiology culture
9.1.5. Next generation sequencing (NGS)
9.1.6. Polymerase chain reaction (PCR)
9.1.7. Rapid & point of care
9.1.8. Other technologies
10. Antimicrobial Resistance Diagnostics Market – By End Use
10.1. Overview
10.1.1. Segment Share Analysis, By End Use, 2024 & 2032 (%)
10.1.2. Diagnostic Laboratories
10.1.3. Hospitals
10.1.4. Pharmaceutical & Biotechnology Companies
10.1.5. Research Institutes
10.1.6. Others
11. Antimicrobial Resistance Diagnostics Market– By Geography
11.1. Introduction
11.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
11.2. North America
11.2.1. Overview
11.2.2. Antimicrobial Resistance Diagnostics Key Manufacturers in North America
11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.2.5. North America Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
11.2.6. North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.2.7. North America Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
11.2.8. U.S.
11.2.8.1. Overview
11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.2.8.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.2.8.4. U.S. Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
11.2.8.5. U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.2.8.6. U.S. Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
11.2.9. Canada
11.2.9.1. Overview
11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.2.9.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.2.9.4. Canada Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
11.2.9.5. Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.2.9.6. Canada Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
11.3. Europe
11.3.1. Overview
11.3.2. Antimicrobial Resistance Diagnostics Key Manufacturers in Europe
11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.3.5. Europe Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
11.3.6. Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.3.7. Europe Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
11.3.8. Germany
11.3.8.1. Overview
11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.8.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.3.8.4. Germany Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
11.3.8.5. Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.3.8.6. Germany Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
11.3.9. UK
11.3.9.1. Overview
11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.9.3. UK Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.3.9.4. UK Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
11.3.9.5. UK Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.3.9.6. UK Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
11.3.10. France
11.3.10.1. Overview
11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.10.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.3.10.4. France Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
11.3.10.5. France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.3.10.6. France Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
11.3.11. Italy
11.3.11.1. Overview
11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.11.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.3.11.4. Italy Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
11.3.11.5. Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.3.11.6. Italy Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
11.3.12. Spain
11.3.12.1. Overview
11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.12.3. Spain Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.3.12.4. Spain Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
11.3.12.5. Spain Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.3.12.6. Spain Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
11.3.13. The Netherlands
11.3.13.1. Overview
11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.13.3. The Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.3.13.4. The Netherlands Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
11.3.13.5. The Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.3.13.6. The Netherlands Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
11.3.14. Sweden
11.3.14.1. Overview
11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.14.3. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.3.14.4. Sweden Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
11.3.14.5. Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.3.14.6. Sweden Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
11.3.15. Russia
11.3.15.1. Overview
11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.15.3. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.3.15.4. Russia Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
11.3.15.5. Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.3.15.6. Russia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
11.3.16. Poland
11.3.16.1. Overview
11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.16.3. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.3.16.4. Poland Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
11.3.16.5. Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.3.16.6. Poland Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
11.3.17. Rest of Europe
11.3.17.1. Overview
11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.17.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.3.17.4. Rest of the Europe Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
11.3.17.5. Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.3.17.6. Rest of the Europe Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
11.4. Asia Pacific (APAC)
11.4.1. Overview
11.4.2. Antimicrobial Resistance Diagnostics Key Manufacturers in Asia Pacific
11.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.4.4. APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.4.5. APAC Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
11.4.6. APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.4.7. APAC Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
11.4.8. China
11.4.8.1. Overview
11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.8.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.4.8.4. China Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
11.4.8.5. China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.4.8.6. China Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
11.4.9. India
11.4.9.1. Overview
11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.9.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.4.9.4. India Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
11.4.9.5. India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.4.9.6. India Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
11.4.10. Japan
11.4.10.1. Overview
11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.10.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.4.10.4. Japan Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
11.4.10.5. Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.4.10.6. Japan Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
11.4.11. South Korea
11.4.11.1. Overview
11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.11.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.4.11.4. South Korea Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
11.4.11.5. South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.4.11.6. South Korea Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
11.4.12. Australia
11.4.12.1. Overview
11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.12.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.4.12.4. Australia Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
11.4.12.5. Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.4.12.6. Australia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
11.4.13. Indonesia
11.4.13.1. Overview
11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.13.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.4.13.4. Indonesia Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
11.4.13.5. Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.4.13.6. Indonesia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
11.4.14. Thailand
11.4.14.1. Overview
11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.14.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.4.14.4. Thailand Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
11.4.14.5. Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.4.14.6. Thailand Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
11.4.15. Philippines
11.4.15.1. Overview
11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.15.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.4.15.4. Philippines Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
11.4.15.5. Philippines Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.4.15.6. Philippines Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
11.4.16. Rest of APAC
11.4.16.1. Overview
11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.16.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.4.16.4. Rest of APAC Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
11.4.16.5. Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.4.16.6. Rest of APAC Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
11.5. Latin America (LATAM)
11.5.1. Overview
11.5.2. Antimicrobial Resistance Diagnostics Key Manufacturers in Latin America
11.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.5.4. LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.5.5. LATAM Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
11.5.6. LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.5.7. LATAM Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
11.5.8. Brazil
11.5.8.1. Overview
11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.8.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.5.8.4. Brazil Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
11.5.8.5. Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.5.8.6. Brazil Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
11.5.9. Mexico
11.5.9.1. Overview
11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.9.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.5.9.4. Mexico Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
11.5.9.5. Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.5.9.6. Mexico Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
11.5.10. Argentina
11.5.10.1. Overview
11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.10.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.5.10.4. Argentina Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
11.5.10.5. Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.5.10.6. Argentina Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
11.5.11. Colombia
11.5.11.1. Overview
11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.11.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.5.11.4. Colombia Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
11.5.11.5. Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.5.11.6. Colombia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
11.5.12. Rest of LATAM
11.5.12.1. Overview
11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.12.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.5.12.4. Rest of LATAM Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
11.5.12.5. Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.5.12.6. Rest of LATAM Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
11.6. Middle East and Africa (MEA)
11.6.1. Overview
11.6.2. Antimicrobial Resistance Diagnostics Key Manufacturers in Middle East and Africa
11.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.6.4. MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.6.5. MEA Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
11.6.6. MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.6.7. MEA Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
11.6.8. Saudi Arabia
11.6.8.1. Overview
11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.8.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.6.8.4. Saudi Arabia Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
11.6.8.5. Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.6.8.6. Saudi Arabia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
11.6.9. United Arab Emirates
11.6.9.1. Overview
11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.9.3. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.6.9.4. United Arab Emirates Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
11.6.9.5. United Arab Emirates Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.6.9.6. United Arab Emirates Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
11.6.10. Israel
11.6.10.1. Overview
11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.10.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.6.10.4. Israel Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
11.6.10.5. Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.6.10.6. Israel Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
11.6.11. Turkey
11.6.11.1. Overview
11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.11.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.6.11.4. Turkey Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
11.6.11.5. Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.6.11.6. Turkey Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
11.6.12. Algeria
11.6.12.1. Overview
11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.12.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.6.12.4. Algeria Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
11.6.12.5. Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.6.12.6. Algeria Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
11.6.13. Egypt
11.6.13.1. Overview
11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.13.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.6.13.4. Egypt Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
11.6.13.5. Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.6.13.6. Egypt Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
11.6.14. Rest of MEA
11.6.14.1. Overview
11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.14.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.6.14.4. Rest of MEA Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
11.6.14.5. Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.6.14.6. Rest of MEA Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
12. Key Vendor Analysis- Antimicrobial Resistance Diagnostics Industry
12.1. Competitive Benchmarking
12.1.1. Competitive Dashboard
12.1.2. Competitive Positioning
12.2. Company Profiles
12.2.1. Abbott Laboratories
12.2.2. Accelerated Diagnostics, USA
12.2.3. Alifax
12.2.4. BD
12.2.5. Beckman Coulter
12.2.6. Becton, Dickinson and Company
12.2.7. BioMerieux
12.2.8. Bio-Rad Laboratories
12.2.9. Danaher
12.2.10. F. Hoffmann-La Roche
12.2.11. GeneFluidics
12.2.12. Hologic, Inc.
12.2.13. Molsid
12.2.14. OpGen
12.2.15. Roche Diagnostics
12.2.16. Thermo Fisher Scientific
12.2.17. Vela Diagnostics
12.2.18. Visby Medical, Inc.
12.2.19. Others
13. 360 Degree Analyst View
14. Appendix
14.1. Research Methodology
14.2. References
14.3. Abbreviations
14.4. Disclaimer
14.5. Contact Us
Related Reports
Credibility and Certifications
Trusted Insights, Certified Excellence! Coherent Market Insights is a certified data advisory and business consulting firm recognized by global institutes.
ISO 9001:2015
ESOMAR Corporate
GDPR Compliance
D-U-N-S Registered
BBB Accreditation
MRS
